药物对比
Dapagliflozin vs Tolbutamide
比较SGLT2抑制剂 Dapagliflozin（Farxiga）与磺脲类 Tolbutamide 治疗2型糖尿病：疗效、心血管获益、低血糖风险及对体重的影响。
此页面暂无可用的对比维度。
临床背景
Patients or clinicians comparing an older sulfonylurea like Tolbutamide to a modern SGLT2 inhibitor like Dapagliflozin for type 2 diabetes treatment options.
结论
Dapagliflozin is typically preferred over Tolbutamide due to superior cardiovascular outcomes and safety profile, though not a one-size-fits-all recommendation.
全部药物对比